Not applicableStudy completedNCT02111889What this trial is testingTumor Kinase Inhibitor Concentrations Measured by PETWho this might be right forDisseminated Malignant Neoplasm Amsterdam UMC, location VUmc 8
Early research (Phase 1)Study completedNCT00498979What this trial is testingSodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersWho this might be right forStage IV Melanoma Case Comprehensive Cancer Center 22
Early research (Phase 1)Looking for participantsNCT06958679What this trial is testingEvaluation of SYS6005 in Patients With Advanced Malignant TumorWho this might be right forB-cell MalignanciesSolid Tumors CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Early research (Phase 1)Looking for participantsNCT05176483What this trial is testingStudy of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid TumorsWho this might be right forRenal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+7 more Exelixis 1,314
Testing effectiveness (Phase 2)Study completedNCT01204203What this trial is testingPilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)Who this might be right forMesothelioma University of Alabama at Birmingham 8
Testing effectiveness (Phase 2)Study completedNCT03665285What this trial is testingA Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid TumorsWho this might be right forAdvanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more NextCure, Inc. 109
Testing effectiveness (Phase 2)Study completedNCT05661578What this trial is testingEvaluate the Safety and Pharmacokinetics of the Intravenous Fixed-Dose Combination (IV FDC) of Tiragolumab and Atezolizumab in Participants With Locally Advanced, Recurrent or Metastatic Solid TumorsWho this might be right forPD-L1-selected Solid Tumors Hoffmann-La Roche 64
Early research (Phase 1)Active Not RecruitingNCT05339685What this trial is testingBL-M02D1 in Patients With Locally Advanced or Metastatic Triple Negative Breast Cancer or Other Solid TumorsWho this might be right forBreast Cancer Sichuan Baili Pharmaceutical Co., Ltd. 82
Early research (Phase 1)WithdrawnNCT02831179What this trial is testingVeliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWho this might be right forFunctional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more Vanderbilt-Ingram Cancer Center
Early research (Phase 1)Study completedNCT03744403What this trial is testingCS1001 in Subjects with Advanced Solid TumorsWho this might be right forAdvanced Solid Tumors CStone Pharmaceuticals 24
Not applicableNot Yet RecruitingNCT07645742What this trial is testingPilot Study of Intermittent Fasting With Immune Checkpoint InhibitorsWho this might be right forCancer (Advanced Stage) West Virginia University 90
Early research (Phase 1)Study completedNCT00750425What this trial is testingPhase 1 Study of the Effect of Ketoconazole on the PK of Multiple Doses of Cediranib in Patients With Solid TumoursWho this might be right forAdvanced Solid Tumors AstraZeneca 46
Not applicableNot Yet RecruitingNCT07540468What this trial is testingSafety Evaluation of Bioactive Glass Based Bone Cement Combined With Ultrasound in Implantation for Metastatic Bone TumorsWho this might be right forAdvanced CancerPain Liao Yun 8
Not applicableStudy completedNCT03595813What this trial is testingIdentifying Immune-related Biomarkers to Predict the Efficacy of Cancer ImmunotherapyWho this might be right forLung Cancer MetastaticLocally Advanced Malignant NeoplasmNon Hodgkin Lymphoma+1 more Institut Paoli-Calmettes 135
Early research (Phase 1)Not Yet RecruitingNCT07567859What this trial is testingHS-10587 in Patients With Advanced Solid TumorsWho this might be right forMTAP Deletion Jiangsu Hansoh Pharmaceutical Co., Ltd. 362
Testing effectiveness (Phase 2)Study completedNCT02307227What this trial is testingPhase II Study With Trastuzumab + Paclitaxel in Locally Advanced HER2+ Tumors or Epirubicin + Taxotere in HER2- TumorsWho this might be right forBreast Neoplasms Centro di Riferimento Oncologico - Aviano 46
Testing effectiveness (Phase 2)Active Not RecruitingNCT05744427What this trial is testingSafety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Jiangsu Alphamab Biopharmaceuticals Co., Ltd 725
Early research (Phase 1)Study completedNCT02070549What this trial is testingTrametinib in Treating Patients With Advanced Cancer With or Without Hepatic DysfunctionWho this might be right forAdvanced Malignant Solid NeoplasmMetastatic Malignant Neoplasm in the LiverMetastatic Malignant Solid Neoplasm+1 more National Cancer Institute (NCI) 46
Early research (Phase 1)Study completedNCT01755390What this trial is testingA Dose Finding Study of XRP6258 in Patients With Advanced Solid TumorsWho this might be right forAdvanced Solid Tumor Sanofi 42
Early research (Phase 1)Ended earlyNCT03936959What this trial is testingLY3434172, a PD-1 and PD-L1 Bispecific Antibody, in Advanced CancerWho this might be right forAdvanced Cancer Eli Lilly and Company 10